Victory Capital Management’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
Other funds holding COGT
Victory Capital Management's COGT Position: Q3 2026 in Review
Victory Capital Management increased its Cogent Biosciences (COGT) stake by 52% in Q3 2026, buying an estimated $2.47M and bringing the position to 196,849 shares worth $6.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1312.
Victory Capital Management first reported a position in COGT in Q1 2018 and has held it in 13 quarters since. 118 funds tracked by Wall St. Rank hold COGT as of Q3 2026.
- Victory Capital Management held 196,849 shares of Cogent Biosciences worth $6.3M as of Q3 2026.
- Victory Capital Management bought 66,924 Cogent Biosciences shares in Q3 2026, an estimated $2.47M.
- Cogent Biosciences made up ﹤0.01% of Victory Capital Management's portfolio in Q3 2026, its #1312 holding.
- Victory Capital Management first reported a position in Cogent Biosciences in Q1 2018 and has held it in 13 quarters since.
- 118 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2026.
Based on Victory Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.